MetaCap

Rafael Statistics

NYSE: RFLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.9197+0.0197 (+2.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Rafael by the numbers

Rafael has a market capitalization of $48.0 million based on 51.39M shares outstanding. With trailing EPS of $-0.58, Rafael is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 35.5% below its 50-day average and 44.9% below its 200-day average.

Average daily trading volume is 140.84K shares, or about $129,530 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RFL valuation vs. peer median

RFL compared with the median of 8 peer companies
MetricRFLPeer medianDifference
Market cap$47.99M$47.11M+2%
Avg. volume140.84K957.84K-85%

Peer median across 8 companies: HRTX, ONCY, NMAD, VRCA, ACRV, TNXP, MIST, HOWL.

Valuation

Market cap
$47.99M
Price / sales (latest FY)
54.90
EPS (TTM)
$-0.58

Price and trading

Previous close
0.90
Open
0.781
Day range
0.8001 – 0.9691
52-week range
0.781 – 3.96
52-week change
-25.83%
Beta
—
Volume
156.49K

Dividends and events

Annual dividend
None
Next earnings date
Dec 10, 2026

Additional statistics

Market Cap
47.99M
Eps
-0.58
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.96
Week52 Low
0.78
Avg Volume
140.84K
Shares Outstanding
51.39M
Ma50
1.43
Ma200
1.67
Earnings Date
Dec 10, 2026
Pct From52w High
-76.78%
Pct From52w Low
17.76%

Related